{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:45:02Z","timestamp":1791233102211,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xinjiang Production and Construction Corps Guiding Science and Technology Plan Projects","award":["2022ZD073"],"award-info":[{"award-number":["2022ZD073"]}]},{"name":"Xinjiang Production and Construction Corps Guiding Science and Technology Plan Projects","award":["2022ZD045"],"award-info":[{"award-number":["2022ZD045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03676-3","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:16:01Z","timestamp":1739636161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mcl-1 downregulation enhances BCG treatment efficacy in bladder cancer by promoting macrophage polarization"],"prefix":"10.1186","volume":"25","author":[{"given":"Caixia","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"4","key":"3676_CR1","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/cas.14774","volume":"112","author":"L Tong","year":"2021","unstructured":"Tong L, Yang H, Xiong W, Tang G, Zu X, Qi L. Circ_100984-mir-432-3p axis regulated c-jun\/ybx-1\/beta-catenin feedback loop promotes bladder cancer progression. Cancer Sci. 2021;112(4):1429\u201342.","journal-title":"Cancer Sci"},{"key":"3676_CR2","doi-asserted-by":"publisher","first-page":"699804","DOI":"10.3389\/fcell.2021.699804","volume":"9","author":"M Chen","year":"2021","unstructured":"Chen M, Nie Z, Li Y, Gao Y, Wen X, Cao H, et al. A new ferroptosis-related lncrna signature predicts the prognosis of bladder cancer patients. Front Cell Dev Biol. 2021;9:699804.","journal-title":"Front Cell Dev Biol"},{"key":"3676_CR3","doi-asserted-by":"crossref","unstructured":"Xu Y, Zeng H, Jin K, Liu Z, Zhu Y, Xu L et al. Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. J Immunother Cancer. 2022;10(3).","DOI":"10.1136\/jitc-2021-003416"},{"issue":"11","key":"3676_CR4","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1158\/1535-7163.MCT-14-1055-T","volume":"14","author":"Z Shang","year":"2015","unstructured":"Shang Z, Li Y, Zhang M, Tian J, Han R, Shyr CR, et al. Antiandrogen therapy with hydroxyflutamide or androgen receptor degradation enhancer asc-j9 enhances bcg efficacy to better suppress bladder cancer progression. Mol Cancer Ther. 2015;14(11):2586\u201394.","journal-title":"Mol Cancer Ther"},{"key":"3676_CR5","doi-asserted-by":"publisher","first-page":"774230","DOI":"10.3389\/fimmu.2021.774230","volume":"12","author":"Q Li","year":"2021","unstructured":"Li Q, Sun L, Liu L, Ran Q, Du X, Yang Q, et al. Chamaejasmenin b, an inhibitor for metastatic outgrowth, reversed m2-dominant macrophage polarization in breast tumor microenvironment. Front Immunol. 2021;12:774230.","journal-title":"Front Immunol"},{"key":"3676_CR6","doi-asserted-by":"publisher","first-page":"799185","DOI":"10.3389\/fonc.2022.799185","volume":"12","author":"W Xue","year":"2022","unstructured":"Xue W, Zhu H, Liu H, He H. Diras2 is a prognostic biomarker and linked with immune infiltrates in melanoma. Front Oncol. 2022;12:799185.","journal-title":"Front Oncol"},{"issue":"1","key":"3676_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1476-4598-12-105","volume":"12","author":"Z Chen","year":"2013","unstructured":"Chen Z, Sangwan V, Banerjee S, Mackenzie T, Dudeja V, Li X, et al. Mir-204 mediated loss of myeloid cell leukemia-1 results in pancreatic cancer cell death. Mol Cancer. 2013;12(1):105.","journal-title":"Mol Cancer"},{"issue":"19","key":"3676_CR8","doi-asserted-by":"publisher","first-page":"19293","DOI":"10.18632\/aging.103766","volume":"12","author":"Y Li","year":"2020","unstructured":"Li Y, Gao X, Wei C, Guo R, Xu H, Bai Z, et al. Modification of mcl-1 alternative splicing induces apoptosis and suppresses tumor proliferation in gastric cancer. Aging. 2020;12(19):19293\u2013315.","journal-title":"Aging"},{"issue":"7","key":"3676_CR9","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1038\/cddis.2014.281","volume":"5","author":"J Yan","year":"2014","unstructured":"Yan J, Zhong N, Liu G, Chen K, Liu X, Su L, et al. Usp9x- and noxa-mediated mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells. Cell Death Dis. 2014;5(7):e1316.","journal-title":"Cell Death Dis"},{"issue":"21","key":"3676_CR10","doi-asserted-by":"publisher","first-page":"24050","DOI":"10.18632\/aging.203585","volume":"13","author":"L Wang","year":"2021","unstructured":"Wang L, Liu G, Bolor-Erdene E, Li Q, Mei Y, Zhou L. Identification of kif4a as a prognostic biomarker for esophageal squamous cell carcinoma. Aging. 2021;13(21):24050\u201370.","journal-title":"Aging"},{"key":"3676_CR11","doi-asserted-by":"crossref","unstructured":"Guerra FS, Rodrigues DA, Fraga C, Fernandes PD. Novel single inhibitor of hdac6\/8 and dual inhibitor of pi3k\/hdac6 as potential alternative treatments for prostate cancer. Pharmaceuticals (Basel). 2021;14(5).","DOI":"10.3390\/ph14050387"},{"issue":"11","key":"3676_CR12","first-page":"2059","volume":"31","author":"YQ Zhang","year":"2015","unstructured":"Zhang YQ, Wang XM, Wang C, Wang FY, Wang XF, Zhao J, et al. Effect of Mcl-1 signaling pathway blockers on apoptosis of mouse macrophages infected with Mycobacterium tuberculosis H37Rv. Chin J Pathophysiology. 2015;31(11):2059\u201364.","journal-title":"Chin J Pathophysiology"},{"issue":"12","key":"3676_CR13","first-page":"2195","volume":"31","author":"XF Wang","year":"2015","unstructured":"Wang XF, Wang XM, Wang C, Wang XF, Zhang YQ, Wu JD, et al. Effects of Mcl-1 silencing on apoptosis of mouse peritoneal macrophages infected with different virulence of Mycobacterium tuberculosis. Chin J Pathophysiology. 2015;31(12):2195\u2013201.","journal-title":"Chin J Pathophysiology"},{"issue":"6","key":"3676_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/nan.12539","volume":"45","author":"C Reeves","year":"2019","unstructured":"Reeves C, Pradim-Jardim A, Sisodiya SM, Thom M, Liu J. Spatiotemporal dynamics of pdgfrbeta expression in pericytes and glial scar formation in penetrating brain injuries in adults. Neuropathol Appl Neurobiol. 2019;45(6):609\u201327.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"02","key":"3676_CR15","first-page":"291","volume":"44","author":"L Zheng","year":"2024","unstructured":"Zheng L, Yu HW, Jin DW, Qian LY. Expression of cox-2, foxa1 and cx43 proteins in cancer tissues of elderly patients with colon cancer and their relationship with pathological characteristics. Chin J Gerontol. 2024;44(02):291\u20133.","journal-title":"Chin J Gerontol"},{"issue":"06","key":"3676_CR16","first-page":"727","volume":"33","author":"XD Jiang","year":"2023","unstructured":"Jiang XD, Yu Q. Inhibiton of targeted knockdown of Cx43 by shRNA on human multiple myeloma cell line MM. 1S. Biotechnology. 2023;33(06):727\u201331.","journal-title":"Biotechnology"},{"issue":"35","key":"3676_CR17","doi-asserted-by":"publisher","first-page":"e12125","DOI":"10.1097\/MD.0000000000012125","volume":"97","author":"Y Lu","year":"2018","unstructured":"Lu Y, Wang XM, Yang P, Han L, Wang YZ, Zheng ZH, et al. Effect of gap junctions on raw264.7 macrophages infected with h37rv. Med (Baltim). 2018;97(35):e12125.","journal-title":"Med (Baltim)"},{"key":"3676_CR18","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3389\/fimmu.2019.02009","volume":"10","author":"A Emmaneel","year":"2019","unstructured":"Emmaneel A, Bogaert DJ, Van Gassen S, Tavernier SJ, Dullaers M, Haerynck F, et al. A computational pipeline for the diagnosis of cvid patients. Front Immunol. 2019;10:2009.","journal-title":"Front Immunol"},{"issue":"12","key":"3676_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for rna-seq data with deseq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"3","key":"3676_CR20","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. Clusterprofiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2(3):100141.","journal-title":"Innov (Camb)"},{"issue":"12","key":"3676_CR21","doi-asserted-by":"publisher","first-page":"8410","DOI":"10.1111\/jcmm.14721","volume":"23","author":"Y Yao","year":"2019","unstructured":"Yao Y, Zhang T, Qi L, Zhou C, Wei J, Feng F, et al. Integrated analysis of co-expression and cerna network identifies five lncrnas as prognostic markers for breast cancer. J Cell Mol Med. 2019;23(12):8410\u20139.","journal-title":"J Cell Mol Med"},{"issue":"42","key":"3676_CR22","doi-asserted-by":"publisher","first-page":"e22438","DOI":"10.1097\/MD.0000000000022438","volume":"99","author":"L Han","year":"2020","unstructured":"Han L, Lu Y, Wang X, Zhang S, Wang Y, Wu F, et al. Regulatory role and mechanism of the inhibition of the mcl-1 pathway during apoptosis and polarization of h37rv-infected macrophages. Med (Baltim). 2020;99(42):e22438.","journal-title":"Med (Baltim)"},{"issue":"4","key":"3676_CR23","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10753-017-0575-8","volume":"40","author":"H Shen","year":"2017","unstructured":"Shen H, Wu N, Wang Y, Han X, Zheng Q, Cai X, et al. Jnk inhibitor sp600125 attenuates paraquat-induced acute lung injury: an in vivo and in vitro study. Inflammation. 2017;40(4):1319\u201330.","journal-title":"Inflammation"},{"key":"3676_CR24","doi-asserted-by":"crossref","unstructured":"Baek SW, Jang IH, Kim SK, Nam JK, Leem SH, Chu IS. Transcriptional profiling of advanced urothelial cancer predicts prognosis and response to immunotherapy. Int J Mol Sci. 2020;21(5).","DOI":"10.3390\/ijms21051850"},{"issue":"9","key":"3676_CR25","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1056\/NEJMoa022148","volume":"349","author":"HB Grossman","year":"2003","unstructured":"Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349(9):859\u201366.","journal-title":"N Engl J Med"},{"issue":"2","key":"3676_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14728214.2017.1336536","volume":"22","author":"K Cumberbatch","year":"2017","unstructured":"Cumberbatch K, He T, Thorogood Z, Gartrell BA. Emerging drugs for urothelial (bladder) cancer. Expert Opin Emerg Drugs. 2017;22(2):149\u201364.","journal-title":"Expert Opin Emerg Drugs"},{"key":"3676_CR27","doi-asserted-by":"crossref","unstructured":"Babjuk M, Burger M, Comperat E, Palou J, Roupret M, van Rhijn B et al. Reply to harry herr\u2019s letter to the editor re: marko babjuk, andreas bohle, maximilian burger, Eau guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur urol. 2017;71:447\u2013\u200961. Eur Urol. 2017;71(6):e173-4.","DOI":"10.1016\/j.eururo.2016.11.029"},{"issue":"19","key":"3676_CR28","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"issue":"5\u20136","key":"3676_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/21681805.2018.1538162","volume":"52","author":"G Danielsson","year":"2018","unstructured":"Danielsson G, Malmstrom PU, Jahnson S, Wijkstrom H, Nyberg T, Thulin H. Bladder health in patients treated with bcg instillations for t1g2-g3 bladder cancer - a follow-up five years after the start of treatment. Scand J Urol. 2018;52(5\u20136):377\u201384.","journal-title":"Scand J Urol"},{"issue":"2","key":"3676_CR30","doi-asserted-by":"publisher","first-page":"e109821","DOI":"10.1128\/Spectrum.01098-21","volume":"9","author":"SC Duffy","year":"2021","unstructured":"Duffy SC, Venkatesan M, Chothe S, Poojary I, Verghese VP, Kapur V, et al. Development of a multiplex real-time pcr assay for mycobacterium bovis bcg and validation in a clinical laboratory. Microbiol Spectr. 2021;9(2):e109821.","journal-title":"Microbiol Spectr"},{"issue":"2","key":"3676_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW. Intracavitary bacillus calmette-guerin in the treatment of superficial bladder tumors. J Urol. 1976;116(2):180\u20133.","journal-title":"J Urol"},{"issue":"10","key":"3676_CR32","doi-asserted-by":"publisher","first-page":"103150","DOI":"10.1016\/j.isci.2021.103150","volume":"24","author":"GF Shpilsky","year":"2021","unstructured":"Shpilsky GF, Takahashi H, Aristarkhova A, Weil M, Ng N, Nelson KJ, et al. Bacillus calmette-guerin \u2018s beneficial impact on glucose metabolism: evidence for broad based applications. Iscience. 2021;24(10):103150.","journal-title":"Iscience"},{"issue":"1","key":"3676_CR33","doi-asserted-by":"publisher","first-page":"1776060","DOI":"10.1080\/2162402X.2020.1776060","volume":"9","author":"W Zhong","year":"2020","unstructured":"Zhong W, Wang B, Yu H, Lin J, Xia K, Hou W, et al. Serum ccl27 predicts the response to bacillus calmette-guerin immunotherapy in non-muscle-invasive bladder cancer. Oncoimmunology. 2020;9(1):1776060.","journal-title":"Oncoimmunology"},{"issue":"3","key":"3676_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2174\/1874467208666150716120945","volume":"9","author":"M Vasekar","year":"2016","unstructured":"Vasekar M, Degraff D, Joshi M. Immunotherapy in bladder cancer. Curr Mol Pharmacol. 2016;9(3):242\u201351.","journal-title":"Curr Mol Pharmacol"},{"issue":"5S","key":"3676_CR35","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S0007-4551(20)30278-2","volume":"107","author":"Y Loriot","year":"2020","unstructured":"Loriot Y, Roupret M. [Immunotherapies in non-muscle invasive bladder cancer: immunotherapies and nmibc]. Bull Cancer. 2020;107(5S):S49\u201355.","journal-title":"Bull Cancer"},{"issue":"1","key":"3676_CR36","doi-asserted-by":"publisher","first-page":"103639","DOI":"10.1016\/j.isci.2021.103639","volume":"25","author":"F Lv","year":"2022","unstructured":"Lv F, Liu H, Zhao G, Zhao E, Yan H, Che R, et al. Therapeutic exosomal vaccine for enhanced cancer immunotherapy by mediating tumor microenvironment. Iscience. 2022;25(1):103639.","journal-title":"Iscience"},{"issue":"06","key":"3676_CR37","first-page":"779","volume":"40","author":"QQ Li","year":"2022","unstructured":"Li QQ, Wang XM, Qiao CL, Gou XL, Sun Z, Zhang L. Effects of Mcl-1 expression on bladder cancer progression and tumor-associated macrophage infiltration. J Shihezi Univ (Natural Sci Edition). 2022;40(06):779\u201385.","journal-title":"J Shihezi Univ (Natural Sci Edition)"},{"key":"3676_CR38","unstructured":"Zhao YY. Efficacy, safety, biomarker analyses of immune checkpoint inhibitors in advanced urothelial carcinoma. Anhui Medical University; 2023. p. 67."},{"key":"3676_CR39","doi-asserted-by":"publisher","first-page":"933855","DOI":"10.3389\/fnmol.2022.933855","volume":"15","author":"K Chen","year":"2022","unstructured":"Chen K, Liang B, Ma W, Wan G, Chen B, Lu C, et al. Immunological and prognostic analysis of psenen in low-grade gliomas: an immune infiltration-related prognostic biomarker. Front Mol Neurosci. 2022;15:933855.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"3676_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrurol.2014.15","volume":"11","author":"G Redelman-Sidi","year":"2014","unstructured":"Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of bcg therapy for bladder cancer\u2013a current perspective. Nat Rev Urol. 2014;11(3):153\u201362.","journal-title":"Nat Rev Urol"},{"key":"3676_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40425-015-0050-8","volume":"3","author":"R Muthuswamy","year":"2015","unstructured":"Muthuswamy R, Wang L, Pitteroff J, Gingrich JR, Kalinski P. Combination of ifnalpha and poly-i:c reprograms bladder cancer microenvironment for enhanced ctl attraction. J Immunother Cancer. 2015;3:6.","journal-title":"J Immunother Cancer"},{"issue":"8","key":"3676_CR42","doi-asserted-by":"publisher","first-page":"e136947","DOI":"10.1371\/journal.pone.0136947","volume":"10","author":"J Zou","year":"2015","unstructured":"Zou J, Shankar N. Roles of tlr\/myd88\/mapk\/nf-kappab signaling pathways in the regulation of phagocytosis and proinflammatory cytokine expression in response to e. Faecalis infection. PLoS ONE. 2015;10(8):e136947.","journal-title":"PLoS ONE"},{"issue":"5","key":"3676_CR43","first-page":"325","volume":"24","author":"CY Xiong","year":"2008","unstructured":"Xiong CY, Guan DW, Liu ZH, Zhen B, Zhao R, Zhu BL. [Changes of phospho-jnk expression during the skin burned wound healing]. Fa Yi Xue Za Zhi. 2008;24(5):325\u20136.","journal-title":"Fa Yi Xue Za Zhi"},{"issue":"2","key":"3676_CR44","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.intimp.2015.08.038","volume":"29","author":"J Gnanaprakasam","year":"2015","unstructured":"Gnanaprakasam J, Estrada-Muniz E, Vega L. The anacardic 6-pentadecyl salicylic acid induces macrophage activation via the phosphorylation of erk1\/2, jnk, p38 kinases and nf-kappab. Int Immunopharmacol. 2015;29(2):808\u201317.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"3676_CR45","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.4049\/jimmunol.170.3.1320","volume":"170","author":"EA Eugenin","year":"2003","unstructured":"Eugenin EA, Branes MC, Berman JW, Saez JC. Tnf-alpha plus ifn-gamma induce connexin43 expression and formation of gap junctions between human monocytes\/macrophages that enhance physiological responses. J Immunol. 2003;170(3):1320\u20138.","journal-title":"J Immunol"},{"issue":"24","key":"3676_CR46","doi-asserted-by":"publisher","first-page":"25845","DOI":"10.18632\/aging.202147","volume":"12","author":"S Wu","year":"2020","unstructured":"Wu S, Xu R, Zhu X, He H, Zhang J, Zeng Q, et al. The long noncoding rna linc01140\/mir-140-5p\/fgf9 axis modulates bladder cancer cell aggressiveness and macrophage m2 polarization. Aging. 2020;12(24):25845\u201364.","journal-title":"Aging"},{"key":"3676_CR47","doi-asserted-by":"publisher","first-page":"572396","DOI":"10.3389\/fphar.2020.572396","volume":"11","author":"S Liu","year":"2020","unstructured":"Liu S, Wang H, Wang M, Hu X, Yang W, Jin R, et al. Comparative efficacy and safety of Chinese herbal injections combined with cyclophosphamide and 5-fluorouracil chemotherapies in treatment of breast cancer: a bayesian network meta-analysis. Front Pharmacol. 2020;11:572396.","journal-title":"Front Pharmacol"},{"key":"3676_CR48","doi-asserted-by":"publisher","first-page":"111257","DOI":"10.1016\/j.intimp.2023.111257","volume":"126","author":"Y Mi","year":"2024","unstructured":"Mi Y, Tang M, Wu Q, Wang Y, Liu Q, Zhu P, et al. Nmaap1 regulated macrophage polarizion into m1 type through glycolysis stimulated with bcg. Int Immunopharmacol. 2024;126:111257.","journal-title":"Int Immunopharmacol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03676-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:16:11Z","timestamp":1739636171000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03676-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3676"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03676-3","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"and content to participate: all animal experiments were complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Research Ethics Committee of Shihezi University (Xinjiang, China). All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All subjects have been approved by the First Affiliated Hospital of Shihezi University. Written informed consent was obtained from each subject.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}